Home › Leukemia › Ohio › Columbus
Pag-aaral pangklinika para sa Leukemia sa Columbus, OH
Isang pag-aaral para sa Leukemia ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Columbus. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Nagre-recruitPhase 3
- Quetzal Site 8, Columbus
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Nagre-recruitPhase 1/2
- Ohio State University, Columbus
Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation
Nagre-recruitPhase 2
- Ohio State University Comprehensive Cancer Center, Columbus
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Nagre-recruitPhase 3
- Ohio State University, Columbus
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Nagre-recruitPhase 1/2
- The Ohio State University Wexner Medical Center, Columbus
Hairy Cell Leukemia Patient Data Registry
Nagre-recruitObservasyonal na pag-aaral
- Ohio State University Comprehensive Cancer Center, Columbus
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
Nagre-recruitPhase 1/2
- Dren Investigational Site, Columbus
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Nagre-recruitPhase 2/3
- Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute, Columbus
Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma
Nagre-recruitPhase 2
- Ohio State University Comprehensive Cancer Center, Columbus
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Nagre-recruitPhase 1
- The James Cancer Hospital and Solove Research Institute, Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Columbus
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
Nagre-recruitPhase 1
- The Ohio State University Wexner Medical Center - James Cancer Hosp, Columbus
Pag-aaral para sa Leukemia sa ibang lungsod
- Houston, TX28 pag-aaral
- Boston, MA25 pag-aaral
- New York City, NY19 pag-aaral
- Los Angeles, CA16 pag-aaral
- Chicago, IL16 pag-aaral
- Durham, NC13 pag-aaral
- Philadelphia, PA12 pag-aaral
- Nashville, TN12 pag-aaral
- Baldwin Park, CA12 pag-aaral
- Milwaukee, WI11 pag-aaral
- Seattle, WA11 pag-aaral
- Aurora, CO10 pag-aaral
Iba pang pag-aaral sa Columbus
- Non-Small Cell Lung Cancer54 pag-aaral
- Kanser (lahat ng uri)39 pag-aaral
- Kanser sa Suso39 pag-aaral
- Kanser sa Ovary39 pag-aaral
- Kanser sa Baga36 pag-aaral
- Acute Myeloid Leukemia34 pag-aaral
- Chronic Lymphocytic Leukemia29 pag-aaral
- Metastatic Cancer26 pag-aaral
- Kanser ng Endometrium26 pag-aaral
- Kanser sa Prostate24 pag-aaral
- Multiple Myeloma24 pag-aaral
- Colorectal Cancer23 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.